Opportunity

CanadaBuys #20180305

INSPQ plans to procure EUROIMMUN Strongyloides and Chikungunya ELISA kits

Posted

October 30, 2026

Respond By

November 14, 2026

Identifier

20180305

NAICS

325413

INSPQ’s public health laboratory plans to procure EUROIMMUN infectious-disease ELISA kits for screening and diagnostic testing. - Government buyer: Institut national de santé publique du Québec (INSPQ), through the Laboratoire de santé publique du Québec (LSPQ), Montréal. - OEM: EUROIMMUN is the only supplier identified in the notice as meeting the laboratory’s requirements. - Products requested: - 75 Anti-Strongyloides ELISA (IgG) kits, part number EI 2290-9601 G. - 9 Anti-Chikungunya Virus ELISA (IgM) kits, part number EI 293a-9601 M. - 4 Anti-Chikungunya Virus ELISA (IgG) kits, part number EI 293a-9601 G. - Notable requirements: Kits must meet the laboratory’s technical and operational needs. The identified kits are compatible with its analyzers and have validated analytical performance; the Chikungunya tests also align with National Microbiology Laboratory (LNM) recommendations. Health Canada authorization and use by other provincial laboratories support the proposed procurement approach. Replacing the kits may require further evaluation and validation and could risk disruption to laboratory services. - Procurement approach: This Advance Contract Award Notice proposes a direct award to EUROIMMUN. It is not a competitive tender; other suppliers may demonstrate that they meet the requirements, after which INSPQ will decide whether to compete the requirement or proceed with the proposed award. - Period: The planned purchasing period is 12 months. No option years or annual subscription are specified.

Description

The Institut national de santé publique du Québec (INSPQ) intends to directly award a supply contract for immunoenzymatic test kits and associated quality controls used to screen for infectious diseases. The intended purchase is 75 Anti-Strongyloides ELISA (IgG) kits, 9 Anti-Chikungunya Virus ELISA (IgM) kits, and 4 Anti-Chikungunya Virus ELISA (IgG) kits from EUROIMMUN. This Advance Contract Award Notice is not a competitive call for tenders; interested suppliers may respond by the closing date to show they can meet the stated requirements, and responses will be used to assess whether a competitive tender should be issued. The intended purchasing period is January 1 to December 31, 2027, with an estimated contract period of 12 months.

View original listing